Arvinas, Inc. (ARVN) vs Contineum Therapeutics, Inc. (CTNM)

A side-by-side comparison of Arvinas, Inc. and Contineum Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Arvinas, Inc. logo
ARVN
Arvinas, Inc.
$483M
$7.49HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Contineum Therapeutics, Inc. logo
CTNM
Contineum Therapeutics, Inc.
$485M
$12.88HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT

Total return — ARVN vs CTNM

growth of $100 · dividends reinvested · last 2y
ARVN -80.7% (-56.0%/yr)CTNM -17.4% (-9.1%/yr)CTNM compounded faster over this window
50100150Start $10020252026$19$83
ARVN CTNM

ARVN vs CTNM: by the numbers

  • •CTNM is the larger company ($485M vs $483M market cap).
  • •ARVN is profitable (2.94% net margin) while CTNM runs a net loss (0.00%).

Metrics side by side

Valuation

MetricARVNCTNM
P/E ratio46.81N/A
P/S ratio1.53N/A
P/B ratio0.862.02

Profitability

MetricARVNCTNM
Gross margin96.43%0.00%
Operating margin-43.75%0.00%
Net margin2.94%0.00%
ROE1.65%-24.02%
ROIC-2.19%-27.22%

Growth (annualized)

MetricARVNCTNM
Revenue CAGR (5Y)72.38%N/A
Total return CAGR (5Y)-38.16%N/A

Frequently asked

Is ARVN or CTNM more profitable?
ARVN runs the higher net margin — ARVN at 2.94% versus CTNM at 0.00%.

Go deeper

Full ARVN analysisFull CTNM analysisInteractive comparison tool

Dig into the metrics

Arvinas P/E ratioArvinas ROEContineum Therapeutics ROEArvinas operating marginContineum Therapeutics operating marginArvinas revenue growthContineum Therapeutics revenue growthArvinas free cash flowContineum Therapeutics free cash flow

Arvinas & Contineum Therapeutics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.